Effects of Epidermal Growth Factor Receptor Concentration on Tumorigenicity of A431 Cells in Nude Mice

Cancer Research

Volumn 46, Issue 9, 1986, Pages 4701-4705

  MacLeod, Carol L ^c   Masui, Hideo ^a  

^a Division of Endocrinology and Metabolism   (United States)

^b Division of Hematology and Oncology   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA HYBRID; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL EXPERIMENT; CANCER GROWTH; CARCINOGENICITY; CELL LINE; GENE AMPLIFICATION; GENE REARRANGEMENT; HEREDITY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SOLID TUMOR;

ANIMALS; EPIDERMAL GROWTH FACTOR; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 0022449386     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Weinberg, R. A. The action of oncogenes in the cytoplasm and nucleus. Science (Wash. DC), 230: 770-776, 1985.
2. Devare, S., Reddy, E., Law, J., Robbins, D., and Aaronson, A. Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product, P28'. Proc. Natl. Acad. Sci. USA, 80: 731–735, 1983.
3. Doolittle, R. F., Hunkapiller, M. W., Hood, L. E., Devare, S. G., Robbins, K. C., Aaronson, S. A., and Antoniades, H. N. Simian sarcoma virus onc gene. v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science (Wash. DC), 221:215-211, 1983.
4. Waterfield, M. D., Scrace, G. T., Whittle, N., Stroobant, P., Johnsson, A., Wasteson, A., Westermark, B., Heldin, C.-H., Huang, J. S., Deuel, T. F. Platelet-derived growth factor is structurally related to the putative transforming protein p28 of simian sarcoma virus. Nature (Lond.), 304: 35-39, 1983.
5. Huang, J. S., Huang, S. S., and Deuel, T. F. Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors. Cell, 39: 79-87, 1984.
6. Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., and Waterfield, M. D. Close similarity of epidermal growth factor receptor and V-erb-B oncogene protein sequences. Nature (Lond.), 307: 521-527, 1984.
7. Lin, C. R., W. S. Chijen, W. Kniijer, L. S. Stolarsky, W. Weber, R. M. Evans, I. M. Verma, G. N. Gill, and M. G. Rosenfeld. Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science (Wash. DC), 224: 843–848, 1984.
8. Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., Downward, J., Mayes, E. L. V., Whittle, N., Waterfield, M. D., and Seeburg, P. H. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309: 418-425 1984.
9. Xu, Y.-H., Ishii, S., Clark, A. J. L., Sullivan, M., Wilson, R. K., Ma, D. P., Roe, B. A., Merlino, G. T., and Pastan, L. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature (Lond.), 309: 806-810, 1984.
10. Duesberg, P. H. Activated proto-onc genes: sufficient or necessary for cancer? Science (Wash. DC), 228: 669-676, 1985.
11. Reddy, E. P., Reynolds, R. K., Santos, E., and Barbacid, M. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature (Lond.), 300: 149-152, 1982.
12. Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., and Chang, E. H. Mechanism of activation of a human oncogene. Nature (Lond.), 300: 143-149, 1982.
13. Stanton, L. W., Fahrlander, P. D., Lesser, P. M., and Marcu, K. B. Nucleotide sequence comparison of normal and translocated murine c-myc genes. Nature (Lond.), 310: 423-425, 1984.
14. Nishikura, K., Ar-Rushdi, Abbas, Erikson, J., Watt, R., Rovera, G., and Croce, C. Differential expression of the normal and of the translocated human c-myc oncogenes in B cells. Proc. Natl. Acad. Sci. USA, 80: 4822–4826, 1983.
15. Gilmore, T., DeClue, J. E., and Martin, G. S. Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro. Cell, 40: 609–618, 1985.
16. Kris, R. M., Lax, I., Gullick, W., Waterfield, M. D., Ullrich, A., Fridkin, M., and Schlessinger, J. Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell, 40: 619–625, 1985.
17. Nilsen, T. W., Maroney, P. A., Goodwin, R. G., Rottman, F. M., Crittenden, L. B., Raines, M. A., and Kung, H.-J. c-erbB activation in ALV-induced erythroblastosis: novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptor. Cell, 41:719-726, 1985.
18. Yamamoto, T., Nishida, T., Miyajima, N., Kawai, S., Ooi, T., and Toyoshima, K. The erbB gene of avian erythroblastosis virus is a member of the src gene family. Cell, 35: 71-78, 1983.
19. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. Amplification enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (Lond.), 313: 144-147, 1985.
20. Filmus, J., Poliak, M. N., Cailleau, R., and Buick, R. N. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem. Biophys. Res. Commun., 128: 898-905, 1985.
21. Hendler, F., Shum, A., Richards, C., Cassels, D., Guasterson, B., and Ozanne, B. Evidence for increased epidermal growth factor receptors in epidermoid malignancies. Cancer Cells, 1:41-50, 1984.
22. King, C. R., Kraus, M. H., and Aaronson, S. A. Amplification of a novel verb B-related gene in a human mammary carcinoma. Science (Wash. DC), 229:974-976, 1985.
23. Gill, G. N., Weber, W., Thompson, D. M., Lin, C., Evans, R. M., Rosenfeld, M. G., Gamou, S., and Shimizu, N. The relation between production of epidermal growth factor receptors, gene amplification, and chromosome 7 translocation in variant A431 cells. Somatic Cell Mol. Genet., 11:309-318, 1985.
24. Buss, J. E., Kudlow, J. E., Lazar, C. S., and Gill, G. N. Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF. Proc. Natl. Acad. Sci. USA, 79: 2574–2578, 1982.
25. Kawamoto, T., Mendelsohn, J., Le, A., Sato, G. H., Lazar, C. S., and Gill, G. N. Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. J. Biol. Chem., 259: 7761-7766, 1984.
26. Gill, G. N., and Lazar, C. S. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature (Lond.), 293: 305–308, 1981.
27. Barnes, D. W. Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture. J. Cell Biol., 93: 1-4, 1982.
28. Gill, G. N., Kawamoto, T., Cochet, C., Le, A., Sato, J. D., Masui, H., MacLeod, C., and Mendelsohn, J. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem., 259: 7755-7760, 1984.
29. Weber, W., P. J. Bertics, and G. N. Gill. Immunoaffinity purification of the epidermal growth factor receptor stoichiometry of EGF binding and kinetics of self-phosphorylation. J. Biol. Chem., 259: 14631-14636, 1984.
30. Kawamoto, T., Sato, J. D., Le, A., Polikoff, J., Sato, G. H., and Mendelsohn, J. Growth stimulation of A431 cells by epidermal growth factor identification of high affinity receptors for epidermal growth factory an anti-receptor monoclonal antibody. Proc. Natl. Acad. Sci. USA, 80: 1337-1341, 1983.
31. Hunter, W. M., and Greenwood, F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (Lond.), 194: 495-496, 1965.
32. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
33. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
34. Thomas, P. S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA, 77: 5201–5205, 1980.
35. Masui, H., Kawamoto, T., Sato, V. D., Wolf, B., Sato, G., and Mendelsohn. V. Growth inhibition of human tumor cells in athymic mice by antiepidermal growth factor receptor monoclonal antibodies. Cancer Res., 44: 1002-1007, 1984.
36. Kudlow, J. E., Khosravi, M. J., Kobrin, M. S., and Mak, W. W. Inability of anti-epidermal growth factor receptor monoclonal antibody to block “autocrine” growth stimulation in transforming growth factor-secreting melanoma cells. J. Biol. Chem., 259: 11895-11900, 1984.
37. Thompson, D. M., and Gill, G. N. The EGF receptor Structure, regulation and potential role in malignancy. Cancer Surv. 4, 767–788, 1985.
38. Shimizu, N., Kondo, I., Gamou, S., Behzadian, M. A., and Shimizu, Y. Genetic analysis of hyperproduction of epidermal growth factor receptors in human epidermoid carcinoma A431 cells. Somatic Cell Genet., 10: 45–53, 1984.
39. Weber, W., Gill, G. N., and Spiess, J. Production of an epidermal growth factor receptor-related protein. Science (Wash. DC), 224: 294-297, 1984.
40. Lifshitz, A., Lazar, C. S., Buss, J. E., and Gill, G. N. Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factor. J. Cell. Physiol., 115: 235-242, 1983.